Q&A: What new drug is the FDA reviewing to treat Parkinson’s disease?

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
BMJ Open

Effect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial

Introduction Although there are some drugs to control Parkinson’s disease (PD), they have several side effects and cannot ...
Business Wire

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease

DUBLIN--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), today announced results from the Phase IIb PADOVA study conducted by partner Roche investigating prasinezumab in 586 people with ...